# MAL

## Overview
The MAL gene encodes the T cell differentiation protein, a proteolipid integral membrane protein that plays a significant role in cellular processes such as T cell signaling and membrane trafficking. The MAL protein is characterized by its four transmembrane domains and is involved in the formation of specialized membrane domains, which are crucial for the recruitment of signaling molecules like the Lck tyrosine kinase to the plasma membrane (Alonso1987cDNA; Antón2008An). This protein is essential for T cell receptor-mediated signaling and the organization of membrane lipids, facilitating specific pathways of membrane trafficking (RubioRamos2021The). Beyond its role in T cells, MAL is also implicated in apical transport in epithelial cells and the architecture of nodes of Ranvier in oligodendrocytes (RubioRamos2021The). Clinically, the MAL gene is associated with various cancers, where its expression and methylation status serve as potential biomarkers for disease prognosis and treatment response (Li2024Research; Labat-de-Hoz2023The).

## Structure
The MAL protein is a highly hydrophobic integral membrane protein associated with T cell differentiation. Its primary structure consists of a sequence encoding a protein with a predicted molecular mass of approximately 16,700 Da (Alonso1987cDNA). The secondary structure of MAL includes four transmembrane domains, which are separated by short hydrophilic segments, suggesting a role in forming channels or pores in the plasma membrane (Alonso1987cDNA). These transmembrane domains are encoded by four exons, each correlating with a hydrophobic segment of the protein (Rancaño1994Genomic).

The MAL protein is classified as a proteolipid due to its lipid-like properties and high hydrophobicity, similar to other proteolipids like PMP-22 and the proteolipid subunit of V-ATPases (Rancaño1994Genomic). It contains a MARVEL domain, which is associated with membrane juxtaposition events (Antón2008An). The protein lacks N-glycosylation sites but contains serines in the COOH terminus, which are potential phosphorylation sites for cAMP- and cGMP-dependent protein kinases (Alonso1987cDNA). MAL is involved in the formation of specialized membrane domains and is crucial for the recruitment of proteins like Lck to the plasma membrane, indicating its role in T cell signaling and membrane trafficking (Antón2008An).

## Function
The MAL protein is an integral component of specialized membranes, playing a crucial role in organizing membrane lipids to create specific condensed membrane environments. These environments selectively recruit molecules for specialized pathways of membrane trafficking and signaling (RubioRamos2021The). In T lymphocytes, MAL is essential for the transport and localization of the Lck tyrosine kinase to the plasma membrane, which is critical for T cell receptor (TCR)-mediated signaling. MAL facilitates the formation of specific transport carriers for Lck, and its absence leads to intracellular accumulation of Lck, impairing TCR signaling and immunological synapse (IS) assembly (RubioRamos2021The; Antón2008An).

MAL is also involved in the apical transport machinery in polarized epithelial cells, aiding in the efficient transport of proteins to the apical surface. It is necessary for the direct route of apical transport and is involved in clathrin-dependent apical endocytosis (RubioRamos2021The). In oligodendrocytes, MAL influences the architecture of nodes of Ranvier, affecting myelin content (RubioRamos2021The). Additionally, MAL is implicated in the generation of intraluminal vesicles and exosome release (RubioRamos2021The).

## Clinical Significance
The MAL gene, also known as myelin and lymphocyte protein, is implicated in various cancers through its altered expression and methylation patterns. Aberrant methylation of the MAL promoter is associated with its silencing in several cancers, including breast, esophageal, and colorectal carcinomas. This hypermethylation serves as a potential early biomarker, particularly in Barrett's-associated esophageal adenocarcinoma, and is linked to poor disease-free survival in gastric cancer (Li2024Research). In cervical cancer, MAL methylation is associated with the extent of cervical pathology, especially in high-risk HPV-positive cases, and serves as a prognostic marker (Li2024Research; Sinha2024MAL). 

In addition to its role in cancer, a missense variant of the MAL gene (p.Ala109Asp) is linked to a rare hypomyelinating leukodystrophy similar to Pelizaeus-Merzbacher disease (Labat-de-Hoz2023The). MAL expression is also associated with resistance to certain treatments in cutaneous T-cell lymphoma and ovarian cancer, where it is highly expressed in platinum-resistant cell lines (Labat-de-Hoz2023The). These findings highlight the clinical significance of MAL in both cancer prognosis and treatment response.

## Interactions
The MAL protein is involved in several key interactions with other proteins, particularly in the context of T cell function and membrane dynamics. MAL physically interacts with the Src family kinase Lck, which is crucial for targeting Lck to the plasma membrane of T cells. This interaction is essential for the formation of transport vesicles that carry Lck, as demonstrated by colocalization studies in Jurkat cells (Antón2008An). The absence of MAL disrupts the formation of these vesicles, leading to defects in T cell receptor (TCR) polarization and microtubule-organizing center reorientation (Antón2008An).

MAL also interacts with proteins involved in the sorting and transport within T lymphocytes, such as LAT, although LAT does not colocalize with MAL-positive transport vesicles (Antón2011MAL). In renal epithelial cells, MAL interacts with transport proteins like NKCC2 and AQP2, stabilizing them at the apical plasma membrane (Tuna2019Mal). MAL is also associated with PLCβ3, where it may regulate its expression and function (Tuna2019Mal).

In the context of Clostridium perfringens ε-toxin (ETX) binding, MAL is necessary for ETX binding and activity, with specific interactions involving the extracellular loops of MAL (Rumah2015The). These interactions highlight MAL's role in various cellular processes through its association with multiple proteins.


## References


[1. (Labat-de-Hoz2023The) Leticia Labat-de-Hoz, Armando Rubio-Ramos, Isabel Correas, and Miguel A. Alonso. The mal family of proteins: normal function, expression in cancer, and potential use as cancer biomarkers. Cancers, 15(10):2801, May 2023. URL: http://dx.doi.org/10.3390/cancers15102801, doi:10.3390/cancers15102801. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15102801)

[2. (Alonso1987cDNA) M A Alonso and S M Weissman. Cdna cloning and sequence of mal, a hydrophobic protein associated with human t-cell differentiation. Proceedings of the National Academy of Sciences, 84(7):1997–2001, April 1987. URL: http://dx.doi.org/10.1073/pnas.84.7.1997, doi:10.1073/pnas.84.7.1997. This article has 126 citations.](https://doi.org/10.1073/pnas.84.7.1997)

[3. (Tuna2019Mal) Kubra M. Tuna, Bing-Chen Liu, Qiang Yue, Zinah M. Ghazi, He-Ping Ma, Douglas C. Eaton, and Abdel A. Alli. Mal protein stabilizes luminal membrane plc-β3 and negatively regulates enac in mouse cortical collecting duct cells. American Journal of Physiology-Renal Physiology, 317(4):F986–F995, October 2019. URL: http://dx.doi.org/10.1152/ajprenal.00446.2018, doi:10.1152/ajprenal.00446.2018. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/ajprenal.00446.2018)

[4. (Rancaño1994Genomic) C. Rancaño, T. Rubio, I. Correas, and M.A. Alonso. Genomic structure and subcellular localization of mal, a human t-cell-specific proteolipid protein. Journal of Biological Chemistry, 269(11):8159–8164, March 1994. URL: http://dx.doi.org/10.1016/s0021-9258(17)37174-0, doi:10.1016/s0021-9258(17)37174-0. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)37174-0)

[5. (Rumah2015The) Kareem Rashid Rumah, Yinghua Ma, Jennifer R. Linden, Myat Lin Oo, Josef Anrather, Nicole Schaeren-Wiemers, Miguel A. Alonso, Vincent A. Fischetti, Mark S. McClain, and Timothy Vartanian. The myelin and lymphocyte protein mal is required for binding and activity of clostridium perfringens ε-toxin. PLOS Pathogens, 11(5):e1004896, May 2015. URL: http://dx.doi.org/10.1371/journal.ppat.1004896, doi:10.1371/journal.ppat.1004896. This article has 71 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.ppat.1004896)

[6. (Antón2008An) Olga Antón, Alicia Batista, Jaime Millán, Laura Andrés-Delgado, Rosa Puertollano, Isabel Correas, and Miguel A. Alonso. An essential role for the mal protein in targeting lck to the plasma membrane of human t lymphocytes. The Journal of Experimental Medicine, 205(13):3201–3213, December 2008. URL: http://dx.doi.org/10.1084/jem.20080552, doi:10.1084/jem.20080552. This article has 67 citations.](https://doi.org/10.1084/jem.20080552)

[7. (Sinha2024MAL) Abarna Sinha, Abhisikta Ghosh, Arnab Ghosh, Sonia Mathai, Jaydip Bhaumik, Asima Mukhopadhyay, Arindam Maitra, Nidhan K. Biswas, and Sharmila Sengupta. Mal expression downregulation through suppressive h3k27me3 marks at the promoter in hpv16-related cervical cancers is prognostically relevant and manifested by the interplay of novel mal antisense long noncoding rna ac103563.8, e7 oncoprotein and ezh2. Clinical Epigenetics, March 2024. URL: http://dx.doi.org/10.1186/s13148-024-01651-9, doi:10.1186/s13148-024-01651-9. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13148-024-01651-9)

[8. (Li2024Research) Mengyao Li, Yan Du, Xianzhuo Zhang, and Wence Zhou. Research advances of mal family members in tumorigenesis and tumor progression (review). Molecular Medicine Reports, February 2024. URL: http://dx.doi.org/10.3892/mmr.2024.13181, doi:10.3892/mmr.2024.13181. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2024.13181)

[9. (Antón2011MAL) Olga M. Antón, Laura Andrés-Delgado, Natalia Reglero-Real, Alicia Batista, and Miguel A. Alonso. Mal protein controls protein sorting at the supramolecular activation cluster of human t lymphocytes. The Journal of Immunology, 186(11):6345–6356, June 2011. URL: http://dx.doi.org/10.4049/jimmunol.1003771, doi:10.4049/jimmunol.1003771. This article has 53 citations.](https://doi.org/10.4049/jimmunol.1003771)

[10. (RubioRamos2021The) Armando Rubio-Ramos, Leticia Labat-de-Hoz, Isabel Correas, and Miguel A. Alonso. The mal protein, an integral component of specialized membranes, in normal cells and cancer. Cells, 10(5):1065, April 2021. URL: http://dx.doi.org/10.3390/cells10051065, doi:10.3390/cells10051065. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells10051065)